Tetra Pak to consolidate its Singapore-based production

Pharmaceutical product packaging accounts for a large part of manufacturers’ Scope 3 emissions, which consider, for example raw material production, manufacturing, and end-of-life disposal. According to Metsä Board studies, fresh fibre paperboard can notably reduce the carbon footprint of pharmaceutical packaging by optimising the paperboard in use. Assessments* conducted by Metsä Board demonstrate the significant carbon footprint reductions that pharmaceutical manufacturers can achieve by switching from commonly used grades to Metsä Board fresh fibre paperboards. The lower carbon footprint of Metsä Board’s folding boxboards, compared to the above mentioned boards, is due to the use of fossil free energy in their production and their lighter weight. However, despite the lighter weight, Metsä Board’s folding boxboards still retain the durability and functional properties of traditional heavier grades.

The red carpet was rolled out as Jim Hammer, president of Hammer Packaging, and his executive team and employees were honored to welcome Koenig & Bauer president and CEO Claus Bolza-Schünemann who arrived from Germany to its headquarters in Rochester, NY. Bolza-Schünemann was especially interested to inspect the new KBA Rapida 106 41-inch eight-color press on Hammer’s pressroom floor, which was installed in July 2017, and how its unique features are assisting Hammer and its customers. With the installation of its new 41-inch KBA eight-color press at its modern two-story headquarters set in an expansive wooded suburban office park near the campus of Rochester Institute of Technology, Hammer is working hand-and-hand with its customers on how it is pioneering a new generation of offset printing. This new configuration is yet another unique layout to its portfolio of presses, says the company, and is making Hammer truly one-of-a-kind. This latest press represents the newest technology available with the fastest press speeds in the world. Click Read More below for additional information.

The Group's consolidated sales amounted to EUR 641.3 million in the first three months of 2021 and thus almost reached the previous year's level (Q1 2020: EUR 646.6 million). At EUR 61.2 million, the operating result was 5.2% or EUR 3.4 million below the previous year's figure (Q1 2020: EUR 64.6 million). An increase in the packaging division was offset by a decline in the cartonboard division. Financial income of EUR 0.5 million (Q1 2020: EUR 0.4 million) was offset by financial expenses of EUR -3.6 million (Q1 2020: EUR -2.1 million). The “other financial result - net” was EUR 0.5 million (Q1 2020: EUR -0.1 million). The profit for the period fell slightly from EUR 45.1 million to EUR 43.9 million.